Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities

Pharmacological Research(2022)10.1016/j.phrs.2022.106409Source: DataRank Database

Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities is a research paper published in Pharmacological Research (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.54)OA: greenTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Ling Wu ORCID,Sherry B. Hildreth,Nancy J. Vogelaar ORCID,Biswarup Mukhopadhyay ORCID,Richard F. Helm ORCID

Live enrichment

PubMed:35995346 PMC:PMC10074477 OpenAlex:https://openalex.org/W4293529815

NIA NIH HHS

Grant: R01 AG058673

NIA NIH HHS

Grant: R03 AG061531

NIA NIH HHS

Grant: R01 AG067607

National Institutes of Health

Grant: 1R03AG061531-01

Pilot Study on Novel Compounds for the Prevention of Aging-related diabetic Hyperamylinemia

National Institutes of Health

Grant: 5R01AG067607-03

Skin biomarkers for diagnosing and characterizing AD and ADRD

National Institutes of Health

Grant: 5R01AG058673-03

Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease

FWCI

1.54

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: CC BY

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10074477/pdf/nihms-1882815.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1043661822003541?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1043661822003541?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10074477

Fields of Study

Alzheimer's disease research and treatmentsComputational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases0301 basic medicine0303 health sciences03 medical and health sciencesAlzheimer DiseaseAmyloid beta-PeptidesAmyloidogenic ProteinsAnimalsAnthraquinonesCatecholsDiabetes Mellitus, Type 2Islet Amyloid PolypeptideOxidation-ReductionProtein AggregatesQuinonesRats

MeSH Terms

Alzheimer DiseaseAnimalsAnthraquinonesCatecholsDiabetes Mellitus, Type 2Oxidation-ReductionQuinonesAmyloid beta-PeptidesRatsAmyloidogenic ProteinsIslet Amyloid PolypeptideProtein Aggregates

Keywords

CatecholInhibitory postsynaptic potentialRedoxChemistryBiochemistryCombinatorial chemistryStereochemistryBiologyNeuroscienceOrganic chemistryRedox RegulationProtein Misfolding DiseasesDrug Library ScreeningCatechol-containing CompoundsHip RatsAggregation Modifying InhibitorsAmyloid beta-PeptidesCatecholsQuinonesAmyloidogenic ProteinsAnthraquinonesIslet Amyloid PolypeptideRatsProtein AggregatesDiabetes Mellitus, Type 2Alzheimer DiseaseAnimalsOxidation-Reduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being